Intelligent Bio Updates FDA 510(k) Progress for Fingerprint Drug Test System, Highlights Accuracy & Readiness

ReutersSep 17, 2025 12:47 PM

Sept 17 (Reuters) - Intelligent Bio Solutions Inc INBS.O:

INTELLIGENT BIO SOLUTIONS PROVIDES UPDATE ON FDA 510(K) CLEARANCE PROCESS FOR INTELLIGENT FINGERPRINTING DRUG SCREENING SYSTEM
INTELLIGENT BIO SOLUTIONS - FDA REQUESTS NEW ADDITIONAL INFORMATION THAT REQUIRES CO TO RESUBMIT NEW 510(K) NOTIFICATION
INTELLIGENT BIO SOLUTIONS - EXPECTS INVESTOR UPDATE IN TEN DAYS OUTLINING UPDATED TIMELINE FOR FDA CLEARANCE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

With a sold-out HBM pipeline, leadership in G9 NAND technology, and a valuation that has yet to fully account for its 2030 trillion-dollar potential, Micron remains a cornerstone "buy" for any long-term tech portfolio.

IONQ First-Quarter Earnings Beat Expectations, Shares Fall After Hours; Is IONQ Still Worth Investing?

TradingKey - IONQ’s latest earnings beat expectations, but shares fell after-hours as the market had previously overextended performance expectations; the medium-to-long-term outlook remains bullish.

Trump Family Mining Firm American Bitcoin Losses Widen, Why the Market Is Still Buying?

American Bitcoin reported widening losses for Q1 2026, yet its stock price remained resilient amid rising Bitcoin prices, with the potential for further gains in the near term.

Dell Stock Analysis: Is It Still Undervalued and the Best AI Infrastructure Play by 2026?

TradingKey - Dell Technologies (DELL) results are due late this month and the setup is unusual. The company is a key provider of AI infrastructure, yet its valuation multiple has expanded much more modestly than peers in the semiconductor, networking, memory, and storage sectors. As we head into ear

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools